November 19, 2013 / 12:42 PM / in 4 years

BRIEF-Intellipharmaceutics U.S.-listed shares up 93.1 percent premarket

NEW YORK, Nov 19 (Reuters) - Intellipharmaceutics International Inc : * U.S.-listed shares up 93.1 percent to $3.65 in premarket; gets final FDA OK to commercially launch 15 and 30 mg generic Focalin XR

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below